Skip to content
drillr.ai
Sign up

SXTC

China Sxt Pharmaceuticals, Inc.

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN

$0.08
+24.00%
Ask drillr

Income statement

MetricTTM2026202520242023
Revenue
Total Revenue1.1M1.1M1.7M1.9M2.0M
Cost of Revenue889.4K889.4K1.4M1.4M1.5M
Gross Profit183.3K183.3K367.4K554.0K426.3K
Operating Expenses
R&D Expense—178.8K191.4K184.2K—
SG&A Expense11.5M7.1M3.0M3.1M6.0M
General & Admin Expense10.7M7.1M2.8M2.6M5.6M
Selling & Marketing Expense809.1K—289.9K433.6K387.5K
Other Expenses(4.2M)—(191.4K)(184.2K)—
Total Operating Expenses7.3M7.3M3.0M3.1M6.0M
Cost and Expenses8.2M8.2M4.4M4.4M7.6M
Operating Income (EBIT)(10.7M)(7.1M)(2.7M)(2.5M)(5.6M)
Non-Operating
Interest Income—————
Interest Expense63.0K63.0K648.2K544.3K476.8K
Net Interest Income(63.0K)(63.0K)(648.2K)(544.3K)(476.8K)
Other Non-Op Income/Expense2.8K1.0M(623.2K)(583.3K)(327.3K)
Non-Operating Income (excl Interest)——(25.0K)39.0K(149.5K)
EBT (Pre-Tax Income)(6.1M)(6.1M)(3.3M)(3.1M)(5.9M)
Income Tax Expense(1.4M)130.8K———
Bottom Line
Net Income(6.2M)(6.2M)(3.3M)(3.1M)(5.9M)
Earnings from Cont. Ops(9.3M)(6.2M)(3.3M)(3.1M)(5.9M)
Earnings from Discont. Ops—————
Bottom Line Net Income(6.2M)(6.2M)(3.3M)(3.1M)(5.9M)
Per Share
Basic EPS($7.95)($9.13)($8.18)($3.57)($22.23)
Diluted EPS($7.95)($9.13)($8.18)($3.57)($22.23)
Revenue Per Share$1.83$1.58$4.31$2.22$7.39
Shares
Basic Shares Outstanding585774679648403920867422266973
Diluted Shares Outstanding585774679648403920867422266973
Profitability Metrics
EBITDA(7.0M)(7.0M)(2.6M)(2.4M)(5.2M)
D&A143.2K143.2K82.3K203.2K250.2K
EBIT(7.1M)(7.1M)(2.7M)(2.6M)(5.5M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026